Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada
Point-of-Care Diagnostic Tests
Lumos develops manufactures and provides direct commercial sale of proprietary, Lumos-branded POC diagnostic tests
SARS-CoV-2 Rapid Antigen Test gives qualified healthcare
providers qualitative, easy-to-interpret results
- Results within 20 minutes
- Easy-to-use: instrument-free, user-friendly test procedure for non-lab settings
- Convenient: all materials included in the kit for hassle-free logistics
Join Us for Antibiotic Awareness Week! November 18-24
Development & Manufacturing Services
Lumos Diagnostics can help your business plan, develop and manufacture customized point-of-care diagnostic solutions
Lumos has specific expertise in developing assays across a range of POC, chemistry and technology platforms. These can be configured as stand-alone, manual-read products or interfaced with Lumos readers or third-party hardware for fully automated solutions.
Lumos has drawn upon its range of optical detector technologies, to configure a range of POC reader platforms for devices needing an objective test result. Our reader platforms act as a starting point to reduce overall product development effort and timeline. They are customizable to meet partner and/or end user needs and price points.
Cloud & Data
Lumos has developed a digital technology platform that enables our clients to leverage the cloud to create an entire product ecosystem that enhances reader capability. We work collaboratively with you to customize our platform and develop a specific solution that fits your business needs.
Reach out to Lumos today to learn more about our customized point-of-care diagnostic solutions!